偉明環保(603568.SH):大股東擬增加一致行動人及在一致行動人之間內部轉讓股份
格隆匯12月29日丨偉明環保(603568.SH)公佈,因資產規劃需要,公司大股東一致行動人王素勤、項淑丹在本公吿披露之日起六個月內擬通過大宗交易方式轉讓不超過600.03萬股給項淑丹、項奕豪為100%持有人的私募基金產品:上海迎水投資管理有限公司-迎水興盛6號私募證券投資基金(“迎水興盛6號”)、上海迎水投資管理有限公司-迎水飛龍20號私募證券投資基金(“迎水飛龍20號”)、上海迎水投資管理有限公司-迎水巡洋12號私募證券投資基金(“迎水巡洋12號”),佔公司目前總股本的0.46%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.